MedPath
HSA Product

SOFILEX FOR ORAL SUSPENSION 125 mg/5 ml

Product approved by Health Sciences Authority (SG)

Basic Information

SOFILEX FOR ORAL SUSPENSION 125 mg/5 ml

POWDER, FOR SUSPENSION

Regulatory Information

SIN10419P

November 16, 1998

Prescription Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XJ01DB01

Company Information

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Active Ingredients

CEPHALEXIN

Strength: 125 mg/5 ml

© Copyright 2025. All Rights Reserved by MedPath